Kimberly Jo Tzoumakas
Director · Starling Oncology, Inc.
Individual
- 2026
- Jul 29, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kimberly Jo Tzoumakas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jorey Chernett - $2.69M in STLN purchases and sales in the last 12 months
- Brad Hively - $2.00M in STLN purchases and sales in the last 12 months
- Mohit Kaushal - $335K in STLN purchases and sales in the last 12 months
- Yale Podnos - $276K in STLN purchases and sales in the last 12 months
- Mark L. Pacala - $200K in STLN purchases and sales in the last 12 months
- Robert Ross Carter - $879 in STLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kimberly Jo Tzoumakas?
Kimberly Jo Tzoumakas is a corporate insider, tracked as Director of Starling Oncology, Inc. (STLN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kimberly Jo Tzoumakas submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
